Trial registration : ClinicalTrials.gov, NCT02117661, Registered April 21, 2014, Similar content being viewed by others Background Metabolic syndrome (MetS) is a group of cardiovascular risk factors that when combined increase the risk of heart disease and stroke
In diabetes care, endocrinologists bring deep knowledge of insulin dynamics, complication management, and complex pharmacotherapy
By: Yekta Dowlati, PhD The advent of GLP-1 receptor agonists (GLP-1 RAs) marks a transformative era in obesity and type 2 diabetes management
Dr Cheung said that unintended pregnancy linked to GLP-1 medications has been on the radar for some time, given nearly half of all pregnancies in Australia are unplanned
The only clear winner in this battle right now
Do not self-administer this injection